Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Terminal nucleotidyltransferase 5B (TENT5B) is a human enzyme encoded by the *TENT5B* gene, previously known as *FAM46B*. It functions as a non-canonical poly(A) polymerase, catalyzing the addition of adenosine to mRNA poly(A) tails, and thus regulates mRNA stability and translation. TENT5B contains a larger N-terminal catalytic domain compared to other eukaryotic poly(A) polymerases and is structurally similar to prokaryotic PAP/CCA-adding enzymes. It is localized to both cytoplasm and nucleus and is highly expressed in human pre-implantation embryos and pluripotent stem cells, but is sharply down-regulated following differentiation. TENT5B is essential for the maintenance of protein synthesis and viability in embryonic stem cells, with knockout causing apoptosis and lethality. Recent studies highlight its critical role in gametogenesis (oogenesis), where its loss leads to infertility, particularly in mouse models[1][2][3][5][8][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Terminal nucleotidyltransferase 5B (TENT5B).